Live Breaking News & Updates on Webcast Of Ascendi Oncology Program

Stay updated with breaking news from Webcast of ascendi oncology program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Ascendis Pharma Oncology Program Update Highlights Latest Clinical Data for Product Candidates

31.05.2023 - – TransCon IL-2 β/γ in Phase 1 clinical trial showed monotherapy clinical activity in heavily pre-treated cancer patients with clear dose dependent response on cytotoxic immune cells – TransCon IL-2 β/γ administered every 3 weeks was . Seite 1 ....

Ascendis Pharma , Jan Mikkelsen , Stina Singel , Webcast Of Ascendi Oncology Program , Company Oncology , Head Of Clinical Development , Ascendi Oncology Program Update , Executive Vice President , Clinical Development ,